Literature DB >> 9272646

cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways.

H A Kim1, J E DeClue, N Ratner.   

Abstract

Schwann cell proliferation is stimulated by contact with neurons or exposure to growth factor ligands for tyrosine kinase receptors, effects of which are potentiated by cAMP. Here we show that treatment of rat Schwann cells with recombinant human glial growth factor 2 (rhGGF2), but not with other mitogenic factors, transiently increases intracellular cyclic AMP (cAMP), with maximal elevation at the G0/G1 boundary. The cAMP-dependent protein kinase (PKA) inhibitor H-89 strongly antagonized GGF- and neuron-induced Schwann cell proliferation, with maximum inhibition observed at G0/G1. H-89 also inhibited Schwann cell proliferation induced by growth factors that did not increase intracellular cAMP. Stimulation of Schwann cells with rhGGF2 resulted in 70-fold activation of MAP kinase; forskolin treatment resulted in a 50% decrease in MAP kinase activity but did not alter Raf-1 phosphorylation on Ser-43. These results demonstrate that the MAP kinase cascade represents an intersection between receptor tyrosine kinase and cAMP signaling pathways in Schwann cells and that PKA plays a critical role in Schwann cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272646

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  39 in total

1.  A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration.

Authors:  W Mandemakers; R Zwart; M Jaegle; E Walbeehm; P Visser; F Grosveld; D Meijer
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB.

Authors:  C Meier; E Parmantier; A Brennan; R Mirsky; K R Jessen
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

4.  Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1.

Authors:  H A Kim; N Ratner; T M Roberts; C D Stiles
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation.

Authors:  Marie C Harrisingh; Elena Perez-Nadales; David B Parkinson; Denise S Malcolm; Anne W Mudge; Alison C Lloyd
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 6.  Signaling axis in schwann cell proliferation and differentiation.

Authors:  Toru Ogata; Shin-ichi Yamamoto; Kozo Nakamura; Sakae Tanaka
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

7.  Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation.

Authors:  Paula V Monje; Sayuri Rendon; Gagani Athauda; Margaret Bates; Patrick M Wood; Mary Bartlett Bunge
Journal:  Glia       Date:  2009-07       Impact factor: 7.452

8.  Transgenic SCs expressing GDNF-IRES-DsRed impair nerve regeneration within acellular nerve allografts.

Authors:  Xueping Ee; Ying Yan; Daniel A Hunter; Lauren Schellhardt; Shelly E Sakiyama-Elbert; Susan E Mackinnon; Matthew D Wood
Journal:  Biotechnol Bioeng       Date:  2017-05-18       Impact factor: 4.530

9.  Brief treatments with forskolin enhance s-phase entry in balance epithelia from the ears of rats.

Authors:  M Montcouquiol; J T Corwin
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

10.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.